![5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one (CAS 5817-96-9) chemical structure](/media/structures/NCIZQRMMYUHTDP-UHFFFAOYSA-N.svg)
VAQORASynonyms: 5H-Pyrrolo[2,3-d]pyrimidin-6(7H)-one · 6H-Pyrrolo[2,3-d]pyrimidin-6-one, 5,7-dihydro- (8CI) · 5H,7H-Pyrrolo[2,3-d]pyrimidin-6-one · 5H-Pyrrolo[23-d]pyrimidin-6(7H)-one
5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one (CAS 5817-96-9) – Tofacitinib impurity standard. C6H5N3O, MW 135.12. Vaqora Chemicals: COA, global shipping.
Listed under CAS 5817-96-9, 5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one is an impurity of Tofacitinib available from Vaqora Chemicals. The compound has the formula C6H5N3O, corresponding to a molecular weight of 135.12 g/mol. Systematically, it is named 5,7-dihydropyrrolo[2,3-d]pyrimidin-6-one. Alternative names: 5H-Pyrrolo[2,3-d]pyrimidin-6(7H)-one and 5H,7H-Pyrrolo[2,3-d]pyrimidin-6-one.
The product is provided as a solid. Store the standard in its sealed vial, protected from light and moisture, and follow the storage condition printed on the COA. Handle it with standard laboratory precautions and appropriate personal protective equipment.
This Tofacitinib impurity supports analytical method development and validation (AMV), batch release testing and the impurity sections of ANDA and DMF filings. Our customers for this product work in pharmaceutical manufacturing and academic and industrial research.
Available in 10 mg, 25 mg, 50 mg and 100 mg packs, 5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one is dispatched with a Certificate of Analysis (COA) to destinations worldwide.
View every impurity, metabolite and intermediate we list for Tofacitinib.
Tofacitinib impurities| Product name | 5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one |
|---|---|
| Catalogue No. | VQ-035285 |
| CAS Number | 5817-96-9 |
| IUPAC name | 5,7-dihydropyrrolo[2,3-d]pyrimidin-6-one |
| Molecular formula | C6H5N3O |
| Molecular weight | 135.12 g/mol |
| Exact mass | 135.0433 |
| Grade | Reference Standard |
| HSN code | 38229090 |
| InChIKey | NCIZQRMMYUHTDP-UHFFFAOYSA-N |
| SMILES | C1C2=CN=CN=C2NC1=O |
| PubChem CID | 15525019 |
| Physical form | Solid |
|---|---|
| LogP (XLogP3) | -0.6 |
| H-bond donors / acceptors | 1 / 3 |
| TPSA | 54.9 Ų |
The CAS Registry Number of 5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one is 5817-96-9. It is also known as 5H-Pyrrolo[2,3-d]pyrimidin-6(7H)-one, 6H-Pyrrolo[2,3-d]pyrimidin-6-one, 5,7-dihydro- (8CI), 5H,7H-Pyrrolo[2,3-d]pyrimidin-6-one.
5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one has the molecular formula C6H5N3O and a molecular weight of 135.12 g/mol. Its IUPAC name is 5,7-dihydropyrrolo[2,3-d]pyrimidin-6-one.
5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one is supplied as a characterised reference material related to Tofacitinib. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.
We supply 5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one in Reference Standard grade, in 10 mg, 25 mg, 50 mg, 100 mg packs. Larger bulk quantities and custom packing are quoted on request.
Yes. Every lot of 5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.
Yes. We export 5H,6H,7H-Pyrrolo[2,3-d]pyrimidin-6-one worldwide by air and sea freight or express courier, on EXW, FOB, CIF, CFR or DAP Incoterms, with full export documentation.
We reply within one business day with price, pack options, lead time and documentation.
![3-((3R,4R)-3-(((5S,6R)-5,6-Dihydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile chemical structure](/media/structures/OTCVGLUFZKDIFV-SUJFGCQRSA-N.svg)
![3-((3R,4R)-3-(((5R,6S)-5,6-Dihydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile chemical structure](/media/structures/OTCVGLUFZKDIFV-QDRWXPAPSA-N.svg)
![4-Chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine chemical structure](/media/structures/LJXVPXRXXVHTBP-UHFFFAOYSA-N.svg)
![N-((3S,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure](/media/structures/UMWNXPTXDOVDFE-MAUKXSAKSA-N.svg)
![Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate chemical structure](/media/structures/IQFJFTIXSPNYQX-ZBFHGGJFSA-N.svg)
Australia
Bangladesh
Belgium
Brazil
Canada
China
Egypt
France
Germany
India
Indonesia
Ireland